tirzepatide vs semaglutide weight loss effectiveness comparison vs. — what's the difference? 🌿 Both are powerful tools for improving MORE PEOPLE NEED TO KNOW

97 Compared to other reference groups receiving non-GLP-1RAs drugs or no treatment, a study including 168 women, who took any one of the GLP-1RAs throughout the first trimester for diabetes or obesity-related illnesses, revealed no increased risk of birth abnormalities or congenital malformations, scoring a value of 2.3%, which aligns with the European Surveillance of Congenital Anomalies value of 2.6%

Conflicts of Interest None of the authors have any conflicts of interests to declare

PloS One (2014) 9(3):e91422

Retatrutide Research Peptide Key Findings Weight Reduction and Body Composition Retatrutide demonstrated substantial reductions in body weight across multiple dose groups, with higher doses producing greater effects